NEW YORK (GenomeWeb News) – Pathway Genomics, a new direct-to-consumer genetic testing firm, launched today, offering genotyping and analysis for disease risk and heredity for under $250.

The San Diego, Calif.-based company said that its on-site lab has been certified by California regulators and has received CLIA clearance. The company said its testing enables customers to learn about disease risk, adverse drug responses, carrier status, and ancestral history.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.